Vitiligo Treatment Without Steroids: A Comprehensive Guide

Vitiligo (autoimmune melanocyte loss) has multiple non-steroid therapies:

First-Line Medical

• Topical calcineurin inhibitors: Tacrolimus 0.1%, pimecrolimus 1% — face/folds, long-term safe.
• Topical JAK inhibitors: Ruxolitinib 1.5% cream (FDA-approved ≥12 yr) — face/body, repigmentation in ~30% at 24 wks.
• Vitamin D analogs: Calcipotriene — adjunct.

Phototherapy

• Narrowband UVB (311 nm): Gold standard. 2–3×/wk; home units available. Best for widespread disease.
• Excimer laser (308 nm): Targeted, high-dose — localized patches.
• PUVA (UVA + psoralen): Less used now (photocarcinogenesis risk).

Surgical (Stable Disease ≥1 yr)

• Suction blister grafting, punch grafting, melanocyte-keratinocyte transplantation (MKTP), cultured melanocytes.

Depigmentation (Extensive >50% BSA)

• Monobenzone 20% — permanent, irreversible. Cosmetic camouflage alternative.

Supportive

• Sun protection (broad-spectrum SPF 50+).
• Cosmetic camouflage (Dermablend, Microskin).
• Stress management, balanced diet, vitamin D supplementation if deficient.
• Psychological support — vitiligo impacts QoL significantly.

Combination therapy (e.g., topical JAKi + NB-UVB) often superior. Treat early; active inflammation responds better.